 | • レポートコード：QYR2104Z4097 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、神経精神障害＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、ショック治療、その他）、用途別市場規模（病院、診療所、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・神経精神障害＆治療の市場動向 ・企業の競争状況、市場シェア ・神経精神障害＆治療の種類別市場規模（薬物治療、ショック治療、その他） ・神経精神障害＆治療の用途別市場規模（病院、診療所、研究センター） ・神経精神障害＆治療の北米市場規模2016-2027（アメリカ、カナダ） ・神経精神障害＆治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・神経精神障害＆治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・神経精神障害＆治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・神経精神障害＆治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Astrazeneca、Glaxosmithkline、Universal Health Services、Boehringer Ingelheim、Eli Lilly） ・結論 |
Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions, eating disorders, depression, and anxiety and others. They can range widely in cause, course, and severity.
The key component of neuropsychiatric disorders is that the symptoms tend to impact brain function, emotion and mood. These can range from problems with focus and learning in the case of ADHD to sadness, irritability, memory problems, mood problems, depression to a variety of other psychiatric and/or neurological symptoms. Medications, psychological and/or psychiatric therapy are common treatments for neuropsychiatric disorders. Specific treatments will vary based on the precise cause, clinical presentation and severity.
Market Analysis and Insights: Global Neuropsychiatric Disorders and Treatment Market
The global Neuropsychiatric Disorders and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuropsychiatric Disorders and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuropsychiatric Disorders and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuropsychiatric Disorders and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuropsychiatric Disorders and Treatment market.
Global Neuropsychiatric Disorders and Treatment Scope and Market Size
Neuropsychiatric Disorders and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuropsychiatric Disorders and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Drug Treatment
Shock Treatment
Others
Segment by Application
Hospitals
Clinics
Research Centres
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Astrazeneca
Glaxosmithkline
Universal Health Services
Boehringer Ingelheim
Eli Lilly
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropsychiatric Disorders and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Shock Treatment
1.2.4 Others
1.3 Market by Application
1.3.1 Global Neuropsychiatric Disorders and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centres
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuropsychiatric Disorders and Treatment Market Perspective (2016-2027)
2.2 Neuropsychiatric Disorders and Treatment Growth Trends by Regions
2.2.1 Neuropsychiatric Disorders and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuropsychiatric Disorders and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Neuropsychiatric Disorders and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Neuropsychiatric Disorders and Treatment Industry Dynamic
2.3.1 Neuropsychiatric Disorders and Treatment Market Trends
2.3.2 Neuropsychiatric Disorders and Treatment Market Drivers
2.3.3 Neuropsychiatric Disorders and Treatment Market Challenges
2.3.4 Neuropsychiatric Disorders and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropsychiatric Disorders and Treatment Players by Revenue
3.1.1 Global Top Neuropsychiatric Disorders and Treatment Players by Revenue (2016-2021)
3.1.2 Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Neuropsychiatric Disorders and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuropsychiatric Disorders and Treatment Revenue
3.4 Global Neuropsychiatric Disorders and Treatment Market Concentration Ratio
3.4.1 Global Neuropsychiatric Disorders and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropsychiatric Disorders and Treatment Revenue in 2020
3.5 Neuropsychiatric Disorders and Treatment Key Players Head office and Area Served
3.6 Key Players Neuropsychiatric Disorders and Treatment Product Solution and Service
3.7 Date of Enter into Neuropsychiatric Disorders and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropsychiatric Disorders and Treatment Breakdown Data by Type
4.1 Global Neuropsychiatric Disorders and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Type (2022-2027)
5 Neuropsychiatric Disorders and Treatment Breakdown Data by Application
5.1 Global Neuropsychiatric Disorders and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
6.2 North America Neuropsychiatric Disorders and Treatment Market Size by Type
6.2.1 North America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
6.2.2 North America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
6.2.3 North America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
6.3 North America Neuropsychiatric Disorders and Treatment Market Size by Application
6.3.1 North America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
6.3.2 North America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
6.3.3 North America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
6.4 North America Neuropsychiatric Disorders and Treatment Market Size by Country
6.4.1 North America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021)
6.4.2 North America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
7.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Type
7.2.1 Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
7.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Application
7.3.1 Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
7.4 Europe Neuropsychiatric Disorders and Treatment Market Size by Country
7.4.1 Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type
8.2.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application
8.3.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region
8.4.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
9.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type
9.2.1 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
9.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application
9.3.1 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
9.4 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country
9.4.1 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type
10.2.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application
10.3.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country
10.4.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Details
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca Neuropsychiatric Disorders and Treatment Introduction
11.1.4 Astrazeneca Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.1.5 Astrazeneca Recent Development
11.2 Glaxosmithkline
11.2.1 Glaxosmithkline Company Details
11.2.2 Glaxosmithkline Business Overview
11.2.3 Glaxosmithkline Neuropsychiatric Disorders and Treatment Introduction
11.2.4 Glaxosmithkline Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.2.5 Glaxosmithkline Recent Development
11.3 Universal Health Services
11.3.1 Universal Health Services Company Details
11.3.2 Universal Health Services Business Overview
11.3.3 Universal Health Services Neuropsychiatric Disorders and Treatment Introduction
11.3.4 Universal Health Services Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.3.5 Universal Health Services Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Neuropsychiatric Disorders and Treatment Introduction
11.4.4 Boehringer Ingelheim Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Neuropsychiatric Disorders and Treatment Introduction
11.5.4 Eli Lilly Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021)
11.5.5 Eli Lilly Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Neuropsychiatric Disorders and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Shock Treatment
Table 4. Key Players of Others
Table 5. Global Neuropsychiatric Disorders and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Neuropsychiatric Disorders and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Neuropsychiatric Disorders and Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Neuropsychiatric Disorders and Treatment Market Share by Regions (2016-2021)
Table 9. Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Neuropsychiatric Disorders and Treatment Market Share by Regions (2022-2027)
Table 11. Neuropsychiatric Disorders and Treatment Market Trends
Table 12. Neuropsychiatric Disorders and Treatment Market Drivers
Table 13. Neuropsychiatric Disorders and Treatment Market Challenges
Table 14. Neuropsychiatric Disorders and Treatment Market Restraints
Table 15. Global Neuropsychiatric Disorders and Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Neuropsychiatric Disorders and Treatment Market Share by Players (2016-2021)
Table 17. Global Top Neuropsychiatric Disorders and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropsychiatric Disorders and Treatment as of 2020)
Table 18. Ranking of Global Top Neuropsychiatric Disorders and Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Neuropsychiatric Disorders and Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Neuropsychiatric Disorders and Treatment Product Solution and Service
Table 22. Date of Enter into Neuropsychiatric Disorders and Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Neuropsychiatric Disorders and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Astrazeneca Company Details
Table 63. Astrazeneca Business Overview
Table 64. Astrazeneca Neuropsychiatric Disorders and Treatment Product
Table 65. Astrazeneca Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 66. Astrazeneca Recent Development
Table 67. Glaxosmithkline Company Details
Table 68. Glaxosmithkline Business Overview
Table 69. Glaxosmithkline Neuropsychiatric Disorders and Treatment Product
Table 70. Glaxosmithkline Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 71. Glaxosmithkline Recent Development
Table 72. Universal Health Services Company Details
Table 73. Universal Health Services Business Overview
Table 74. Universal Health Services Neuropsychiatric Disorders and Treatment Product
Table 75. Universal Health Services Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 76. Universal Health Services Recent Development
Table 77. Boehringer Ingelheim Company Details
Table 78. Boehringer Ingelheim Business Overview
Table 79. Boehringer Ingelheim Neuropsychiatric Disorders and Treatment Product
Table 80. Boehringer Ingelheim Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 81. Boehringer Ingelheim Recent Development
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Neuropsychiatric Disorders and Treatment Product
Table 85. Eli Lilly Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuropsychiatric Disorders and Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drug Treatment Features
Figure 3. Shock Treatment Features
Figure 4. Others Features
Figure 5. Global Neuropsychiatric Disorders and Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Centres Case Studies
Figure 9. Neuropsychiatric Disorders and Treatment Report Years Considered
Figure 10. Global Neuropsychiatric Disorders and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Neuropsychiatric Disorders and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Neuropsychiatric Disorders and Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Neuropsychiatric Disorders and Treatment Market Share by Regions (2022-2027)
Figure 14. Global Neuropsychiatric Disorders and Treatment Market Share by Players in 2020
Figure 15. Global Top Neuropsychiatric Disorders and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropsychiatric Disorders and Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Neuropsychiatric Disorders and Treatment Revenue in 2020
Figure 17. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027)
Figure 21. North America Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027)
Figure 22. North America Neuropsychiatric Disorders and Treatment Market Share by Country (2016-2027)
Figure 23. United States Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027)
Figure 27. Europe Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027)
Figure 28. Europe Neuropsychiatric Disorders and Treatment Market Share by Country (2016-2027)
Figure 29. Germany Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Share by Region (2016-2027)
Figure 39. China Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Neuropsychiatric Disorders and Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Astrazeneca Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021)
Figure 59. Glaxosmithkline Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021)
Figure 60. Universal Health Services Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021)
Figure 62. Eli Lilly Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の筋骨格系障害治療市場規模・現状・予測（2021年-2027年） Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body's movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon Market Analysis and Insights: G…- 世界の双極性障害治療市場規模・現状・予測（2021年-2027年） Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Market Analysis and Insights: Global Bipolar Disorders and Treatment Market The global Bipolar Disorders and Treat…
- 世界の代謝障害治療市場規模・現状・予測（2021年-2027年） Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. Market Analysis and Insights: Global Metabolic Disorders Treatment Market The global Metabol…
- 世界の代謝障害治療市場規模・現状・予測（2021年-2027年） Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. Market Analysis and Insights: Global Metabolic Disorders Treatment Market The global Metabol…
- 世界の甲状腺障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Thyroid Gland Disorders Treatment Market The global Thyroid Gland Disorders Treatment market size is projected to reach US$ 2032.7 million by 2026, from US$ 1782.6 million in 2019, at a CAGR of 1.9% during 2021-2026. With industry-standard accuracy in analysis an…